US2014094432A1PendingUtilityA1
Methods and systems for polymer precipitation and generation of particles
Est. expiryOct 2, 2032(~6.2 yrs left)· nominal 20-yr term from priority
Inventors:J. Michael Ramstack
A61K 47/59A61K 47/61A61K 47/6951A61K 47/4823
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Processes for precipitating polymers from a polymer-containing solution are disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A process for precipitating a cyclodextrin-containing polymer (CDP) -camptothecin conjugate, from a polymer-containing solution, the process comprising: providing a vessel containing a volume of a cooled non-solvent; agitating the cooled non-solvent; introducing the polymer-containing solution into the cooled non-solvent to form a mixture comprising a liquid and the CDP-camptothecin conjugate; and maintaining the mixture under conditions to precipitate at least a portion of the CDP-camptothecin conjugate, from the mixture, thereby precipitating at least a portion of the CDP-camptothecin conjugate.
2 . The process of claim 1 , wherein the CDP-camptothecin conjugate is CRLX101.
3 . The process of claim 1 , wherein the mixture is maintained at a temperature of about −50 to about −100 degrees Celsius.
4 . The process of claim 1 , further comprising removing at least a portion of the liquid from the vessel subsequent to precipitation of the CDP-camptothecin conjugate, thereby separating the precipitated CDP-camptothecin conjugate, from the mixture.
5 . The process of claim 1 , wherein the precipitated CDP-camptothecin conjugate is filtered at a temperature of about −50 degrees Celsius to about −100 degrees Celsius.
6 . The process of claim 5 , wherein the filtered precipitated CDP-camptothecin conjugate is stored in the cooled non-solvent.
7 . The process of claim 1 , wherein the cooled non-solvent comprises acetone.
8 . The process of claim 1 , wherein the temperature of the cooled non-solvent is from about −50 to about −100 degrees Celsius.
9 . The process of claim 8 , wherein the temperature of the cooled non-solvent is about −78 degrees Celsius.
10 . A process for generating particles, comprising:
providing a vessel containing a cooled non-solvent; agitating the cooled non-solvent; introducing a polymer-containing solution comprising a CDP-camptothecin conjugate into the cooled non-solvent to form a mixture comprising a liquid and the CDP-camptothecin conjugate; and maintaining the mixture under conditions to precipitate at least a portion of the CDP-camptothecin conjugate from the mixture, thereby precipitating at least a portion of the CDP-camptothecin conjugate; and isolating at least a portion of the precipitated CDP-camptothecin conjugate; and suspending the precipitated CDP-camptothecin conjugate in an aqueous solution, thereby generating particles.
11 . The process of claim 10 , wherein the CDP-camptothecin conjugate is CRLX101.
12 . The process of claim 10 , wherein the pH of the aqueous solution is from about 2 to about 6.
13 . The process of claim 10 , wherein the cooled non-solvent comprises methanol, ethanol, acetone, n-propanol, isopropanol, n-butanol, ethyl ether, methyl isobutyl ketone or ethyl acetate or a combination thereof.
14 . The process claim 10 , further comprising filtering the particles.
15 . The process of claim 14 , further comprising collecting the particles.
16 . The process of claim 15 , further comprising lyophilizing the collected particles.
17 . A plurality of particles generated according to the process of claim 10 .
18 . The plurality of particles of claim 17 , wherein the particles are nanoparticles.
19 . A preparation comprising the CDP-camptothecin conjugate precipitated by the process of claim 1 .
20 . The preparation of claim 19 , wherein the CDP-camptothecin conjugate is CRLX101.
21 . A system for precipitating a CDP-camptothecin conjugate from a polymer-containing solution, the system comprising:
a vessel for containing a fluid, the vessel having at least one input port and an output port; a cooling system in communication with the vessel configured to cool and maintain the temperature of the fluid in the vessel; wherein said input port is configured to allow introduction of the polymer-containing solution into the vessel to precipitate at least a portion of the CDP-camptothecin conjugate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.